---
title: Antiphospholipid syndrome
author: Harvey Guo
created: <% tp.file.creation_date() %>
modified: <% tp.file.last_modified_date() %>
aliases: <% tp.file.title %>
share: true
---
Antiphospholipid syndrome (APS) is an autoimmune disease associated with <span style="background:rgba(240, 200, 0, 0.2)">increased risk of thrombosis due to the presence of procoagulatory antibodies.</span>
# Pathophysiology
- Formation of procoagulatory antiphospholipid antibodies 
	- Antibodies form complexes with anticoagulant proteins, thereby inactivating them (e.g., protein C, protein S, antithrombin III).
	- Antibodies activate platelets and vascular endothelium. 
- Induction of a hypercoagulable state → ↑ risk of thrombosis and embolism
# Clinical features
APS usually manifests with recurring thrombotic events that may affect any organ.
Pregnancy-related: recurrent miscarriages and premature births.(Caused by thrombosis of [placental](https://next.amboss.com/us/article/Do01VS#Z414c23d8bf8265247dd2e1e7e9b0d89c) vessels and possible subsequent [placental](https://next.amboss.com/us/article/Do01VS#Z414c23d8bf8265247dd2e1e7e9b0d89c) [infarction](https://next.amboss.com/us/article/VP0GdT#Zb11fb76135fecdea9dd3e778dbe469e3))
<mark style="background: #BBFABBA6;">Thrombosis in APS is typically unprovoked (e.g., unprovoked DVT), recurrent, and/or manifests in unusual sites (e.g., kidneys, liver, retina). It is most commonly seen in younger individuals (less than 50 years of age) and in individuals with comorbid autoimmune diseases (e.g., [[Systemic lupus erythematosus|SLE]]).</mark>
# Diagnose
Antiphospholipid antibodies ([aPL antibodies](https://next.amboss.com/us/article/hR0c5f#Zc64f6e326ddf58b2bc9a198ed8f87dd2))
- Lupus anticoagulant (LA): [antibodies](https://next.amboss.com/us/article/x50Emg#Zcafc1c81671c54115ab5d77c08d696a0) against certain phospholipids in [cellular membranes](https://next.amboss.com/us/article/Lo0wcS#Z4224d324188134290d99f44a379e40f9)
- <mark style="background: #FFF3A34A;">Anticardiolipin antibodies</mark> ([IgG](https://next.amboss.com/us/article/x50Emg#Zdcbaf6f4b43f0363afdf3d6aaacd924c) and [IgM](https://next.amboss.com/us/article/x50Emg#Ze9de183a682c9f06a4bdba89dd15ca26))
- Anti-β2-glycoprotein antibodies ([IgG](https://next.amboss.com/us/article/x50Emg#Zdcbaf6f4b43f0363afdf3d6aaacd924c) and [IgM](https://next.amboss.com/us/article/x50Emg#Ze9de183a682c9f06a4bdba89dd15ca26))